Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants.
Z. Liu, H. Wu, K. A. Egland, T. C. Gilliland, M. D. Dunn, T. C. Luke, E. J. Sullivan, W. B. Klimstra, C. L. Bausch, S. P. J. Whelan
This paper describes a fully human immunoglobulin from transchromosomic bovines that neutralizes SARS-CoV-2 variants, including those with mutations like E484K and N501Y.
bioRxiv · Feb 6, 2021Microbiology